St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr

At St. Elisabeth Gruppe GmbH Katholische Kliniken Rhein-Ruhr, the Rheumazentrum Ruhrgebiet is conducting clinical research focused on immune system diseases and related immune system processes. The studies center on inflammatory conditions that affect daily function and quality of life, with an emphasis on understanding how new treatments may support long-term disease control.

• Psoriatic arthritis and treatment effectiveness
• Sjögren’s syndrome and long-term safety
• Active idiopathic inflammatory myopathy and symptom management

The research activity here is aimed at evaluating whether newer therapies can provide lasting benefit while remaining safe and well tolerated for people living with chronic inflammatory rheumatic disease.

This site also contributes to research in musculoskeletal diseases and musculoskeletal and neural physiological phenomena, reflecting a strong focus on disorders that involve pain, stiffness, weakness, and impaired movement. The clinical trials are designed to better understand how targeted therapies may improve disease activity in autoimmune conditions affecting muscles and joints.

• Polymyositis and dermatomyositis
• Idiopathic inflammatory myopathy
• Functional impact of inflammatory muscle disease

These studies are exploring new treatment options and assessing whether they can improve outcomes for patients with complex inflammatory muscle disorders.

Clinical trials at this hospital-based research site also extend into skin and connective tissue diseases, where autoimmune inflammation can affect both internal organs and visible tissues. The work supports a broader effort to test therapies that may reduce disease activity and offer more durable control of chronic immune-related illness.

• Sjögren’s syndrome as a connective tissue disease
• Dermatomyositis with skin involvement
• Inflammation affecting connective tissue and glands

Overall, the research program is centered on improving treatment effectiveness, confirming long-term tolerability, and advancing care for patients with autoimmune conditions seen in rheumatology practice.